CATALOGO DEI PRODOTTI DELLA RICERCA

FERRARI, Sergio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 12.101
EU - Europa 8.958
AS - Asia 6.839
SA - Sud America 1.068
Continente sconosciuto - Info sul continente non disponibili 316
AF - Africa 201
OC - Oceania 31
Totale 29.514
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.708
RU - Federazione Russa 3.569
SG - Singapore 2.671
CN - Cina 2.117
GB - Regno Unito 1.538
IT - Italia 1.070
BR - Brasile 849
HK - Hong Kong 591
VN - Vietnam 584
SE - Svezia 566
FR - Francia 504
DE - Germania 456
IE - Irlanda 449
FI - Finlandia 326
KR - Corea 229
CA - Canada 208
BD - Bangladesh 107
IN - India 98
UA - Ucraina 97
AR - Argentina 82
JP - Giappone 67
ID - Indonesia 62
ZA - Sudafrica 59
NL - Olanda 58
PL - Polonia 57
BE - Belgio 53
ES - Italia 50
TR - Turchia 50
IQ - Iraq 40
MX - Messico 39
EC - Ecuador 32
AT - Austria 30
AU - Australia 28
CO - Colombia 28
IR - Iran 28
NG - Nigeria 28
VE - Venezuela 25
IL - Israele 21
LT - Lituania 21
CL - Cile 20
JM - Giamaica 20
SA - Arabia Saudita 20
TG - Togo 20
PK - Pakistan 19
SV - El Salvador 18
CR - Costa Rica 17
CW - ???statistics.table.value.countryCode.CW??? 17
GT - Guatemala 17
HN - Honduras 17
MA - Marocco 16
UZ - Uzbekistan 16
AE - Emirati Arabi Uniti 15
EG - Egitto 14
GR - Grecia 13
NI - Nicaragua 13
BJ - Benin 12
JO - Giordania 12
PR - Porto Rico 11
LB - Libano 10
PH - Filippine 10
RO - Romania 10
TN - Tunisia 10
TT - Trinidad e Tobago 10
AL - Albania 9
CH - Svizzera 9
DO - Repubblica Dominicana 9
KE - Kenya 9
PT - Portogallo 9
PY - Paraguay 9
BG - Bulgaria 8
CZ - Repubblica Ceca 8
KZ - Kazakistan 8
MY - Malesia 8
SY - Repubblica araba siriana 8
UY - Uruguay 8
HR - Croazia 7
OM - Oman 7
BO - Bolivia 6
LV - Lettonia 6
NP - Nepal 6
PE - Perù 6
SC - Seychelles 6
TW - Taiwan 6
KG - Kirghizistan 5
DZ - Algeria 4
EE - Estonia 4
GE - Georgia 4
LU - Lussemburgo 4
ML - Mali 4
NO - Norvegia 4
BA - Bosnia-Erzegovina 3
BY - Bielorussia 3
DK - Danimarca 3
HU - Ungheria 3
KH - Cambogia 3
PA - Panama 3
RS - Serbia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AO - Angola 2
AZ - Azerbaigian 2
Totale 29.160
Salva come PNG Salva come JPEG
Città #
Ashburn 1.605
Singapore 1.365
Southend 1.233
San Jose 1.180
Moscow 1.153
Dallas 1.039
Chandler 1.003
Jacksonville 626
Hong Kong 581
Woodbridge 534
Verona 434
Dublin 432
Beijing 390
Council Bluffs 373
The Dalles 312
Ann Arbor 285
New York 244
Houston 239
Los Angeles 221
Ho Chi Minh City 191
Wilmington 170
Lawrence 163
Princeton 163
Jinan 126
Hanoi 116
Shenyang 116
Nanjing 112
Helsinki 107
Santa Clara 106
Buffalo 96
Hebei 92
Munich 82
São Paulo 81
Redmond 74
Sindelfingen 73
Redondo Beach 72
Tianjin 69
Dearborn 68
Milan 68
Columbus 64
Chicago 62
Montreal 61
Ningbo 55
Warsaw 52
Washington 52
Tokyo 51
Changsha 50
Hangzhou 49
Orem 49
Brussels 46
Atlanta 45
Guangzhou 45
London 45
Zhengzhou 45
Jakarta 44
Rome 44
Turku 43
Boardman 42
Denver 42
Nanchang 42
Seattle 42
Bologna 41
Brooklyn 41
Carrboro 41
Seoul 41
Falls Church 39
Phoenix 39
Frankfurt am Main 37
Haikou 37
Lancaster 36
Dong Ket 34
Taizhou 33
Boston 31
Johannesburg 31
Nuremberg 31
Toronto 31
Haiphong 30
Redwood City 29
Stockholm 29
Taiyuan 29
Norwalk 27
Rio de Janeiro 27
Abuja 26
Chennai 26
San Francisco 26
Jiaxing 25
Paris 25
Fuzhou 23
Lappeenranta 23
Adelaide 22
Kent 22
Philadelphia 21
Amsterdam 20
Belo Horizonte 20
Fairfield 20
Florence 20
Lomé 20
Da Nang 19
Falkenstein 19
Poplar 19
Totale 17.574
Salva come PNG Salva come JPEG
Nome #
Allelic origin of protease-sensitive and protease-resistant prion protein isoforms in Gerstmann-Sträussler-Scheinker Disease with the P102L mutation. 281
Clinical spectrum and IgG subclass analysis of anti-myelin oligodendrocyte glycoprotein antibody-associated syndromes: a multicenter study 280
Complement-mediated demyelination in patients with IgM monoclonal gammopathy and polyneuropathy 274
A pediatric case of Miller Fisher syndrome with central involvement. 274
Autologous cellular vaccine overcomes cancer immunoediting in a mouse model of myeloma 268
Acute inflammatory demyelinating polyneuropathy as a manifestation of chronic lymphoproliferative disorder of NK cells. 266
Diagnosis of human prion disease using real-time quaking-induced conversion testing of olfactory mucosa and cerebrospinal fluid samples 264
Benign acute viral myositis in African migrants: a clinical, serological and pathological study. 256
Psychological Considerations in the Assessment and Treatment of Pain in Neurorehabilitation and Psychological Factors Predictive of Therapeutic Response: Evidence and Recommendations from the Italian Consensus Conference on Pain in Neurorehabilitation 251
Antisulfatide polyneuropathy: antibody-mediated complement attack on peripheral myelin 245
Cyclooxygenase 2, toll-like receptor 4 and interleukin 1beta mRNA expression in atherosclerotic plaques of type 2 diabetic patients. 245
A novel mutation of aprataxin associated with ataxia ocular apraxia type 1: Phenotypical and genotypical characterization 243
Neurofilament light chain serum levels reflect disease severity in MOG-Ab associated disorders 242
Antibody response against HERV-W env surface peptides differentiates multiple sclerosis and neuromyelitis optica spectrum disorder 236
Mesenchymal stromal cells (MSCs) induce ex vivo proliferation and erythroid commitment of cord blood haematopoietic stem cells (CB-CD34+ cells) 231
A 49-year-old man with neuropsychiatric symptoms followed by progressive cognitive decline. 229
A test for Creutzfeldt-Jakob disease using nasal brushings. 224
Alpha-synuclein seeds in olfactory mucosa of patients with isolated REM sleep behaviour disorder 224
A 58-year-old man with B-cell chronic lymphocytic leukemia and multiple strokes 224
Humoral immunity response to HERV-K/W differentiates between amyotrophic lateral sclerosis and other neurological diseases 222
Relevance of antibodies to myelin oligodendrocyte glycoprotein in CSF of seronegative cases 220
Anti-N-methyl-d-aspartate receptor encephalitis causing a prolonged depressive disorder evolving to inflammatory brain disease. 219
Anti-Ma-associated encephalomyeloradiculopathy in a patient with pleural mesothelioma. 219
Detection of pathologic prion protein in the olfactory epithelium in sporadic Creutzfeldt-Jakob disease 218
Analysis of mammalian scrapie protein by novel monoclonal antibodies recognizing distinct prion protein glycoforms: an immunoblot and immunohistochemical study at the light and electron microscopic levels. 218
Brentuximab vedotin: axonal microtubule's Apollyon 216
Cytoskeletal changes in cultured human fibroblasts following exposure to 2,5-hexanedione 211
Unusual case of solitary intraparenchymal brain plasmacytoma. 210
High diagnostic accuracy of RT-QuIC assay in a prospective study of patients with suspected sCJD 210
Assessing and treating pain in movement disorders, amyotrophic lateral sclerosis, severe acquired brain injury, disorders of consciousness, dementia, oncology and neuroinfectivology. Evidence and recommendations from the Italian Consensus Conference on Pain in Neurorehabilitation 208
RFC1 AAGGG repeat expansion masquerading as Chronic Idiopathic Axonal Polyneuropathy 208
Antibody response against HERV-W in patients with MOG-IgG associated disorders, multiple sclerosis and NMOSD 206
Benign course of tumour-like multiple sclerosis. Report of five cases and literature review. 204
Clinical and neurophysiological serial assessments of brentuximab vedotin-associated peripheral neuropathy 202
Microglial and Neuronal TDP-43 Pathology in Anti-IgLON5-Related Tauopathy 199
Apraxia of eyelid closure in autopsy-confirmed vascular progressive supranuclear palsy. 198
Atypical BSE (BASE) transmitted from asymptomatic aging cattle to a primate. 196
Variable presentations of TTR-related familial amyloid polyneuropathy in seventeen patients. 195
Nervous system: subclinical target of SARS-CoV-2 infection 195
Cauda equina syndrome caused by lumbosacral epidural lipomatosis. A case report. 194
Intraspecies transmission of BASE induces clinical dullness and amyotrophic changes 193
Axonal neuropathy due to myelin protein zero mutation misdiagnosed as amyloid neuropathy 190
Neurological symptoms and axonal damage in COVID-19 survivors: are there sequelae? 190
Chronic fatigue syndrome: an emerging sequela in COVID-19 survivors? 188
Antibodies to neurofascin, contactin-1, and contactin-associated protein 1 in CIDP: Clinical relevance of IgG isotype 186
Serology study after BTN162b2 vaccination in participants previously infected with SARS-CoV-2 in two different waves versus naïve 186
Neurological complications in adult allogeneic hematopoietic stem cell transplant patients: Incidence, characteristics and long-term follow-up in a multicenter series 185
Endothelial adhesion molecule expression is unaltered in the peripheral nerve from patients with AIDS and distal sensory polyneuropathy 184
Identification of distinct N-terminal truncated forms of prion protein in different Creutzfeldt-Jakob disease subtypes. 184
Sural nerve biopsy: current role and comparison with serum neurofilament light chain levels 182
Serum and CSF neurofilament light chain levels in antibody-mediated encephalitis 181
CIDP, CMT1B, or CMT1B plus CIDP? 178
Antibodies to MOG in CSF only: pathological findings support the diagnostic value 178
Oligoclonal bands: clinical utility and interpretation cues 177
The original histological slides of Camillo Golgi and his discoveries on neuronal structure 176
Guillain-Barré syndrome and COVID-19: an observational multicentre study from two Italian hotspot regions 176
Polyneuropathy with anti-sulfatide and anti-MAG antibodies: Clinical, neurophysiological, pathological features and response to treatment. 175
MOG antibody seropositivity in a patient with encephalitis: beyond the classical syndrome 175
Myelin uncompaction and axo-glial detachment in chronic ataxic neuropathy with monospecific IgM antibody to ganglioside GD1b 175
Increased expression of the normal cellular isoform of prion protein in inclusion-body myositis, inflammatory myopathies and denervation atrophy 174
Serum and cerebrospinal neurofilament light chain levels in patients with acquired peripheral neuropathies 171
Role of HIV in the pathogenesis of distal symmetrical peripheral neuropathy 170
Human peripheral nerve macrophages in normal and pathological conditions 166
Cerebrospinal fluid markers in sporadic Creutzfeldt-Jakob disease. 166
Mycobacterium avium subspecies paratuberculosis and myelin basic protein specific epitopes are highly recognized by sera from patients with Neuromyelitis optica spectrum disorder 166
Hypothalamic-Bulbar MRI hyperintensity in Anti-IgLON5 disease with serum-restricted antibodies: a case report and systematic review of literature 165
Neurological complications of HIV infection in pre-HAART and HAART era: a retrospective study 164
Cognitive Profile in Adult Patients With Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease: A Comparative Study With Multiple Sclerosis 163
Anti-MOG-associated demyelinating disorders: two sides of the same coin 162
Phosphorylated 14-3-3zeta protein in the CSF of neuroleptic-treated patients 160
Epileptic seizures of suspected autoimmune origin: a multicentre retrospective study 160
Late presentation of NMOSD as rapidly progressive leukoencephalopathy with atypical clinical and radiological findings 159
GABA(A) receptor autoimmunity after alemtuzumab treatment for multiple sclerosis 159
Autoimmune movement disorders complicating treatment with immune checkpoint inhibitors 158
Peripheral nerve vasculitis: a clinico-pathological study 158
Diagnostic features of initial demyelinating events associated with serum MOG-IgG 157
Further evidence that mutations in FGD4/frabin cause Charcot-Marie-Tooth disease type 4H. 155
Clinical Neuropathology image 1-2018: Golgi silver staining, the black reaction 154
Autoimmune encephalitis misdiagnosis and mimics 153
Frequency and clinical correlates of anti-neural IgM antibodies in neuropathy associated with IgM monoclonal gammopathy 153
Is there a correlation between MOGAD and SARS-CoV-2 infection? 153
Pentraxin-3 and VEGF in POEMS syndrome: A 2-year longitudinal study. 152
Progressive multifocal leukoencephalopathy in a patient with Good's syndrome. 150
HCV-related nervous system disorders. 150
Investigating paraneoplastic aquaporin-4 positive neuromyelitis optica spectrum disorder through a data-driven approach 148
Inter-center agreement in the interpretation of oligoclonal bands 148
HIV-associated PML presenting as epilepsia partialis continua 147
Mechanisms of nerve damage in neuropathies associated with hematological diseases: lesson from nerve biopsies 147
Primary neurolymphomatosis as clinical onset of chronic lymphocytic leukemia 146
A novel cell-based immunofluorescence assay for the detection of autoantibodies to myelin-associated glycoprotein 146
ACUTE ONSET OF PARANODOPATHY ASSOCIATED WITH ANTI-CASPR1 ANTIBODIES AND PROMINENT CRANIAL NERVES INVOLVEMENT 145
GFAP as a marker of astrocytic damage correlated with medication overuse in migraine 145
Identification of a second bovine amyloidotic spongiform encephalopathy: molecular similarities with sporadic Creutzfeldt-Jakob disease. 145
Novel prion protein conformation and glycotype in Creutzfeldt-Jakob disease 145
Demyelinating polyradiculoneuritis following Coxiella burnetti infection (Q fever) 144
Hepatitis C virus-associated neurocognitive and neuropsychiatric disorders: Advances in 2015 144
Cerebrospinal fluid analysis and the determination of oligoclonal bands 144
Clearance of 14-3-3 protein from cerebrospinal fluid heralds the resolution of bacterial meningitis. 143
La guaina mielinica causa di neuropatia. Identificazione delle radicolonevriti demielinizzanti. 142
SARS-CoV-2 encephalitis is a cytokine release syndrome: evidences from cerebrospinal fluid analyses 141
Totale 18.902
Salva come PNG Salva come JPEG
Categoria #
all - tutte 107.761
article - articoli 104.682
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 3.079
Totale 215.522
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022872 0 0 0 189 31 70 19 64 50 54 119 276
2022/20232.874 203 294 265 490 226 706 33 201 323 23 72 38
2023/20241.552 67 101 147 166 148 350 66 92 17 86 211 101
2024/20254.074 242 270 147 639 191 123 225 223 648 306 336 724
2025/202612.198 841 862 887 1.929 3.036 787 1.075 728 918 643 197 295
2026/20272.201 164 282 410 1.345 0 0 0 0 0 0 0 0
Totale 29.514